J.A. Levi

2.0k total citations
13 papers, 676 citations indexed

About

J.A. Levi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, J.A. Levi has authored 13 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in J.A. Levi's work include Testicular diseases and treatments (4 papers), Lung Cancer Research Studies (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). J.A. Levi is often cited by papers focused on Testicular diseases and treatments (4 papers), Lung Cancer Research Studies (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). J.A. Levi collaborates with scholars based in Australia, New Zealand and Belgium. J.A. Levi's co-authors include David Bell, R. N. HITCHINS, R. Woods, Derek Raghavan, VJ Harvey, D. Dalley, R. S. Aroney, Wing‐Kai Chan, Robert L. Woods and Z. Kerestes and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The American Journal of Medicine.

In The Last Decade

J.A. Levi

13 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. Levi Australia 8 408 298 281 192 136 13 676
Robert G. Gagliano United States 11 216 0.5× 320 1.1× 150 0.5× 86 0.4× 101 0.7× 16 673
P.D. Simmonds United Kingdom 9 79 0.2× 215 0.7× 116 0.4× 77 0.4× 90 0.7× 13 469
Santiágo Díez Spain 10 132 0.3× 305 1.0× 134 0.5× 111 0.6× 110 0.8× 13 722
Dorothy Pearson United Kingdom 9 106 0.3× 168 0.6× 88 0.3× 66 0.3× 35 0.3× 13 543
Katarína Rejleková Slovakia 14 205 0.5× 401 1.3× 258 0.9× 41 0.2× 31 0.2× 61 674
L. Vrints Netherlands 13 88 0.2× 125 0.4× 157 0.6× 86 0.4× 97 0.7× 21 536
Cathryn B. Howarth United States 8 158 0.4× 154 0.5× 119 0.4× 53 0.3× 31 0.2× 11 375
Syed A. Mehdi United States 14 213 0.5× 158 0.5× 172 0.6× 89 0.5× 66 0.5× 36 494
H Niibe Japan 11 165 0.4× 183 0.6× 107 0.4× 97 0.5× 60 0.4× 47 441
D E Austin United Kingdom 9 99 0.2× 105 0.4× 109 0.4× 73 0.4× 21 0.2× 12 405

Countries citing papers authored by J.A. Levi

Since Specialization
Citations

This map shows the geographic impact of J.A. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Levi more than expected).

Fields of papers citing papers by J.A. Levi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Levi. The network helps show where J.A. Levi may publish in the future.

Co-authorship network of co-authors of J.A. Levi

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Levi. A scholar is included among the top collaborators of J.A. Levi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Levi. J.A. Levi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Toner, Guy C., Michael Boyer, Michael Jones, et al.. (2001). Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. The Lancet. 357(9258). 739–745. 75 indexed citations
2.
Bishop, James F., J Dewar, Guy C. Toner, et al.. (1997). A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.. PubMed. 24(5 Suppl 17). S17–5. 9 indexed citations
3.
Beith, Jane, Stephen Clarke, Robert L. Woods, David Bell, & J.A. Levi. (1996). Long-term follow-up of a randomised trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung. European Journal of Cancer. 32(3). 438–443. 42 indexed citations
4.
Levi, J.A., Derek Raghavan, VJ Harvey, et al.. (1993). The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group.. Journal of Clinical Oncology. 11(7). 1300–1305. 102 indexed citations
5.
Stuart‐Harris, R., D. Dalley, David Bell, et al.. (1993). Ifosfamide combination regimens for soft-tissue sarcoma.. PubMed. 31 Suppl 2. S185–8. 6 indexed citations
6.
Goldstein, David, J.A. Levi, Robert L. Woods, et al.. (1989). Double-Blind Randomized Cross-Over Trial of Dexamethasone and Prochlorperazine as Anti-Emetics for Cancer Chemotherapy. Oncology. 46(2). 105–108. 16 indexed citations
7.
Levi, J.A., et al.. (1989). Sequential moderate-dose methotrexate and 5-fluorouracil in advanced gastric adenocarcinoma. Cancer Chemotherapy and Pharmacology. 24(1). 67–8. 7 indexed citations
8.
Harnett, Paul R., David Bell, Brian L. Hillcoat, et al.. (1988). Cisplatin plus VP16-213 in advanced ovarian carcinoma. Gynecologic Oncology. 30(2). 159–162. 5 indexed citations
9.
Raghavan, Derek, B M Colls, J.A. Levi, et al.. (1988). Surveillance for Stage I Non‐seminomatous Germ Cell Tumours of the Testis: the Optimal Protocol Has Not Yet Been Defined. British Journal of Urology. 61(6). 522–526. 65 indexed citations
10.
HITCHINS, R. N., David Bell, R. Woods, & J.A. Levi. (1987). A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.. Journal of Clinical Oncology. 5(10). 1655–1662. 270 indexed citations
11.
Stuart‐Harris, R., R. M. Fox, Derek Raghavan, et al.. (1985). Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.. Thorax. 40(5). 346–350. 4 indexed citations
12.
Dalgleish, Angus, Robert L. Woods, J.A. Levi, et al.. (1983). THE ROLE OF HEPATITIS B VIRUS IN THE ETIOLOGY OF HEPATOCELLULAR CARCINOMA IN AUSTRALIA. Australian and New Zealand Journal of Medicine. 13(6). 605–607. 7 indexed citations
13.
Aroney, R. S., D. Dalley, Wing‐Kai Chan, David Bell, & J.A. Levi. (1981). Meningeal carcinomatosis in small cell carcinoma of the lung. The American Journal of Medicine. 71(1). 26–32. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert G. Gagliano Breakdown of academic impact, for papers by P.D. Simmonds Breakdown of academic impact, for papers by Santiágo Díez Breakdown of academic impact, for papers by Dorothy Pearson Breakdown of academic impact, for papers by Katarína Rejleková Breakdown of academic impact, for papers by L. Vrints Breakdown of academic impact, for papers by Cathryn B. Howarth Breakdown of academic impact, for papers by Syed A. Mehdi Breakdown of academic impact, for papers by H Niibe Breakdown of academic impact, for papers by D E Austin
Rankless by CCL
2026